Following a bold earnings surprise, UPS is betting on a strategic pivot away from low-margin deliveries. While 2026 promises a challenging start, management forecasts a powerful second-half rebound fueled by cost cuts and a focus on healthcare and SMBs.
As the U.S. wine industry grapples with a multi-year slump, iconic tasting rooms are shuttering. The latest casualty is Hall of Fame NFL coach Dick Vermeil's Napa venue, a move reflecting broader shifts in consumer habits and market pressures.
In a major strategic shift, UPS announced plans to eliminate up to 30,000 positions and close 24 facilities by 2026. The logistics giant is restructuring its network to prioritize automation and higher-margin business segments, while scaling back lower-margin volume, notably from Amazon. The move aims to reshape the company's cost structure and profitability profile amid a challenging multi-year stock performance.
The FDA's approval of a repeat treatment protocol for Glaukos's iDose TR implant transforms it from a one-time procedure into a potential chronic therapy platform, reshaping its commercial narrative and investor calculus in the competitive glaucoma market.
In a revealing moment during Tesla's earnings call, Elon Musk disclosed that his Saturdays are dedicated to the company's next-generation AI5 chip project, signaling a fundamental strategic shift from automaker to vertically integrated AI hardware powerhouse.
A revised price target for Haivision Systems (TSX:HAI) is shifting the investment narrative, prompting a closer look at the video streaming technology firm's prospects amid evolving market conditions.
The unraveling of the R&R Family of Companies is sending shockwaves through the freight industry, with a new lawsuit from Vantage Carrier alleging over $1.3 million in unpaid invoices. The case adds to a growing pile of legal claims and exposes the precarious financial exposure of carriers and small operators caught in the wake.
Samsara Inc. is emerging as the operational backbone for major food and beverage companies, driving tangible safety and efficiency gains. Yet, its stock appears undervalued against this growing strategic relevance in critical supply chains.
Despite a robust drug pipeline and steady long-term gains, AstraZeneca's recent share price stagnation has investors questioning its true worth. A deep dive into valuation models suggests the pharmaceutical giant may be trading at a significant discount to its intrinsic value, even as its P/E ratio appears elevated compared to peers.
The planned acquisition of craft beverage distributor Point Blank by industry giant Columbia Distributing will result in the closure of two Oregon facilities and impact 177 workers, despite assurances of a 'seamless' transition for partners.
Ichor Holdings (ICHR) shares have taken investors on a rollercoaster, soaring over 64% in a month before a sharp 9% single-day drop. With the semiconductor equipment maker posting revenue near $1 billion alongside net losses, the market is grappling with how to price its future in a cyclical industry. We examine whether the pullback presents a buying opportunity or a warning sign.
Boeing reports a surge in orders and finalizes its Spirit AeroSystems buyout, aiming to solidify its supply chain. However, ongoing production challenges and regulatory scrutiny cast a shadow over its ambitious ramp-up plans.
Novo Nordisk's newly launched oral GLP-1 drug, amycretin, has seen explosive initial demand in the U.S., potentially setting the stage for a significant financial turnaround and stock rally after a challenging previous year.
Drivers across the Midwest are feeling the pinch as regional gasoline prices rose for a second consecutive week, with the current average now sitting 9 cents higher than last month. While still below the national average, the steady increase signals potential pressure on household budgets.
As the restaurant industry navigates post-2025 challenges of traffic recovery and margin pressure, the franchise model emerges as a defensive cornerstone for investors, offering scalability and predictable cash flows.
Drivers across the Midwest are feeling another pinch at the pump as regional gasoline averages rose for a second consecutive week, now sitting just below the national average.
Bernstein raises UPS price target to $128, citing robust fourth-quarter results that help balance a softer margin outlook. The logistics giant's strategic pivot away from low-margin Amazon business and ongoing cost-cutting measures shape its 2026 trajectory.
The FDA's Priority Review for Vyvgart's label expansion in myasthenia gravis accelerates Argenx's growth strategy, while investors weigh the company's broader pipeline against its current valuation.
Altria Group names CFO Salvatore Mancuso as its incoming CEO, accelerating its smoke-free transition while taking a massive impairment charge on past investments, signaling a sharp strategic reassessment.
UBS Group's shares have retreated from recent highs, prompting investors to weigh its current price against robust multi-year performance and the ongoing integration of Credit Suisse. Is the Swiss banking giant fairly valued, or is the market overlooking future risks?
